Some comparative aspects of rifampicin and isoniazid.
作者信息
Canetti G, Le Lirzin M, Porven G, Rist N, Grumbach F
出版信息
Tubercle. 1968 Dec;49(4):367-76. doi: 10.1016/s0041-3879(68)80017-0.
PMID:4975544
Abstract
摘要
相似文献
1
Some comparative aspects of rifampicin and isoniazid.利福平与异烟肼的一些比较方面。
Tubercle. 1968 Dec;49(4):367-76. doi: 10.1016/s0041-3879(68)80017-0.
2
Resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis.结核分枝杆菌菌株对利福平和异烟肼的耐药性。
J Clin Pathol. 1981 Aug;34(8):927-9. doi: 10.1136/jcp.34.8.927.
3
Suitability of rifampicin for intermittent administration in the treatment of tuberculosis.利福平间歇给药治疗结核病的适用性。
Tubercle. 1970 Mar;51(1):82-94. doi: 10.1016/0041-3879(70)90131-5.
4
Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin.异烟肼、乙胺丁醇和利福平的体外及体内动力学与临床应用的相关性。
Am Rev Respir Dis. 1973 Jun;107(6):1013-21. doi: 10.1164/arrd.1973.107.6.1013.
5
[Sensitivity to rifampicin and ethambutol of mycobacteria resistant to isoniazid or streptomycin].[对异烟肼或链霉素耐药的分枝杆菌对利福平和乙胺丁醇的敏感性]
G Ital Chemioter. 1972 Jan-Jun;19(2):20-2.
6
Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India.印度古吉拉特邦的原发性耐结核病及获得性利福平耐药情况。
Tubercle. 1988 Mar;69(1):37-42. doi: 10.1016/0041-3879(88)90038-4.
7
[Critical concentration for definition of rifampicin resistance of tubercle bacilli].[结核杆菌利福平耐药性定义的临界浓度]
Kekkaku. 1972 May;47(5):113-9.
8
Mutant prevention concentration of isoniazid, rifampicin and rifabutin against Mycobacterium tuberculosis.异烟肼、利福平和利福布汀对结核分枝杆菌的突变预防浓度
Chemotherapy. 2005 May;51(2-3):76-9. doi: 10.1159/000085613. Epub 2005 May 4.
9
[Emergent strains of rifampicin-resistant Mycobacterium tuberculosis complex and susceptibility to isoniazid].[耐利福平结核分枝杆菌复合群的新发菌株及对异烟肼的敏感性]
Enferm Infecc Microbiol Clin. 2013 Aug-Sep;31(7):486-7. doi: 10.1016/j.eimc.2013.01.011. Epub 2013 Apr 26.
10
Comment on: isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.关于《缅甸仰光结核分枝杆菌分离株中异烟肼和利福平耐药相关突变：对快速分子检测的意义》的评论
J Antimicrob Chemother. 2011 Mar;66(3):686-7; author reply 687. doi: 10.1093/jac/dkq492. Epub 2010 Dec 21.
引用本文的文献
1
Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.结核病化疗：细菌应激和损伤反应途径对药物疗效的影响。
Clin Microbiol Rev. 2006 Jul;19(3):558-70. doi: 10.1128/CMR.00060-05.
2
Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.结核分枝杆菌耐药性的演变：临床与分子视角
Antimicrob Agents Chemother. 2002 Feb;46(2):267-74. doi: 10.1128/AAC.46.2.267-274.2002.
3
Resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis.结核分枝杆菌菌株对利福平和异烟肼的耐药性。
J Clin Pathol. 1981 Aug;34(8):927-9. doi: 10.1136/jcp.34.8.927.
4
Chemotherapy of drug-resistant tuberculosis.耐多药结核病的化疗
Br Med J. 1969 Aug 30;3(5669):487. doi: 10.1136/bmj.3.5669.487.
5
Tuberculous meningitis in children.儿童结核性脑膜炎
Br Med J. 1971 Jan 2;1(5739):1-2.
6
Rifampicin-induced immune thrombocytopenia.利福平诱导的免疫性血小板减少症。
Br Med J. 1970 Jul 4;3(5713):24-6. doi: 10.1136/bmj.3.5713.24.
7
Potentially serious side effects of high-dose twice-weekly rifampicin.高剂量每周两次利福平潜在的严重副作用。
Br Med J. 1971 Aug 7;3(5770):343-7. doi: 10.1136/bmj.3.5770.343.
8
Effect of rifampicin and isoniazid on liver function.利福平与异烟肼对肝功能的影响。
Br Med J. 1972 Jan 15;1(5793):148-50. doi: 10.1136/bmj.1.5793.148.
9
Actions of the rifamycins.利福霉素的作用。
Bacteriol Rev. 1971 Sep;35(3):290-309. doi: 10.1128/br.35.3.290-309.1971.
10
Rifampicin: a review.利福平：综述
Drugs. 1971;1(5):354-98. doi: 10.2165/00003495-197101050-00002.
Zotero 插件